Search alternatives:
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
i levels » _ levels (Expand Search), 1 levels (Expand Search), 6 levels (Expand Search)
i large » _ large (Expand Search), via large (Expand Search), i larvae (Expand Search)
a large » _ large (Expand Search)
b large » _ large (Expand Search), _ larger (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
i levels » _ levels (Expand Search), 1 levels (Expand Search), 6 levels (Expand Search)
i large » _ large (Expand Search), via large (Expand Search), i larvae (Expand Search)
a large » _ large (Expand Search)
b large » _ large (Expand Search), _ larger (Expand Search)
-
121
-
122
-
123
-
124
-
125
-
126
Supplementary Material for: Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
Published 2021“…In OCI-Ly3/DOX cells, NF-κB activity and PRDM1 expression decreased with an increase in drug-resistant index, whereas <i>MDR1</i> expression increased with enhanced drug resistance. …”
-
127
-
128
-
129
-
130
-
131
-
132
SURF6 knockdown affects cell cycle distribution of HCT116 human intestinal carcinoma cells.
Published 2023Subjects: -
133
-
134
SURF6 co-localizes with ITS2 part of pre-rRNA in the nucleoli of HeLa cells.
Published 2023Subjects: -
135
Table1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.docx
Published 2024“…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …”
-
136
Image1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG
Published 2024“…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …”
-
137
DataSheet_1_Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.xlsx
Published 2021“…The genes most frequently altered (> 20%) were (in decreasing order of frequency) CDKN2A, PIM1, CD79B, TP53, MYD88, MYC, BTG2, BTG1, CDKN2B, DTX1, CD58, ETV6, and IRF4. …”
-
138
Image_1_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg
Published 2023“…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …”
-
139
Foldases and holdases each decrease the level of unfolded protein.
Published 2020“…The benefit of a large spare foldase capacity can be seen from the rapid rise of the unfolded level [<i>U</i>], up 4-fold for only a 2-fold increase in unfolding load (thin black lines). …”
-
140